Showing results (191-200 of 319) with videos related to

Sort By:
Pageof 32
Biological & Pharmaceutical Bulletin|April 3, 2020
Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive StudySatoshi Dote, Daisuke Yamaguchi, Daiki Hira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cellsTobias Mueller, Tomohiro Terada, Ian M Rosenberg, et al.
Peptides|February 18, 2006
Effect of novel NOP receptor ligands on food intake in ratsDaina Economidou, Federica Policani, Teresa Angellotti, et al.
Biological & Pharmaceutical Bulletin|April 3, 2020
Transport Characteristics of 5-Aminosalicylic Acid Derivatives Conjugated with Amino Acids via Human H+-Coupled Oligopeptide Transporter PEPT1Tatsushi Yuri, Yusuke Kono, Tomofumi Okada, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipientsMasahide Fukudo, Ikuko Yano, Satohiro Masuda, et al.
Pharmaceutical Research|February 27, 2004
Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseasesYuji Sakurai, Hideyuki Motohashi, Harumasa Ueo, et al.
Pharmacogenetics and Genomics|April 15, 2008
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patientsMasahide Fukudo, Ikuko Yano, Atsushi Yoshimura, et al.
Drug Metabolism and Pharmacokinetics|January 7, 2014
Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinineTomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
Reduction in gastrointestinal toxicity by gastric secretion inhibitors during S-1 monotherapy for patients with gastric cancerYugo Chisaki, Satoshi Noda, Daiki Hira, et al.
Scientific Reports|February 2, 2021
Alterations in cellular and organellar phospholipid compositions of HepG2 cells during cell growthTokuji Tsuji, Shin-Ya Morita, Yoshinobu Nakamura, et al.
Pageof 32